Analysis of non enzymatic glycosylation in vivo: Impact of different dialysis solutions

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Ho dac Pannekeet, Marja M ^a,c   Weiss, Miriam F ^b   De Waart, Dirk R ^a   Erhard, P ^b   Hiralall, Johan K ^a   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glucose; Glycated proteins; Non enzymatic glycosylation; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; GLUCOSE; ICODEXTRIN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PENTOSIDINE; PERITONEAL DIALYSIS FLUID;

CLINICAL ARTICLE; CONFERENCE PAPER; DIALYSATE; GLYCATION; HUMAN; OSMOLALITY; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; ULTRAFILTRATION;

EID: 0033395801     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s11     Document Type: Conference Paper

References (26)

1. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron. 1996; 72:171-6.
2. Mateijsen MAM, vd Wal AC, Hendriks PMEM, Zweers MM, Mulder J, Krediet RT. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis [Abstract]. J Am Soc Nephrol. 1997; 8:268A-9A.
3. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int. 1994; 14(Suppl 3):S16-20.
4. Gotloib L, Bar-Sella P, Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum. Perit Dial Bull. 1985; 5:212-15.
5. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997; 51:182-6.
6. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, et al. Immunohistochemical study of human advanced glycosylation end-products in chronic renal failure. Clin Nephrol. 1994; 42:354-61.
7. Vlassara H. Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif. 1994; 12:54-9.
8. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991; 325:836-42.
9. Lamb E, Cattell WR, Dawnay A. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci. 1993; 84: 619-26.
10. Lamb EJ, Cattell WR, Dawnay ABStJ. In vitro formation of advanced glycosylation end products in peritoneal dialysis fluids. Kidney Int. 1995; 47:1768-74.
11. Dawnay ABStJ, Millar DJ. Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int. 1997; 17:52-8.
12. Davin JC, Bouts AHM, Krediet RT, van der Weel M, Weening RS, Groothoff J, et al. IgG glycation and function during continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1997; 12:310-4.
13. Friedlander MA, Wu YC, Elgawish A, Monnier VM. Kinetics of formation of early and advanced glycosylation end products in peritoneal dialysis patients. J Clin Invest. 1996; 97:728-35.
14. Wu YC, Monnier VM, Friedlander M. Reliable determination of furosine in human serum and dialysate proteins by high performance liquid chromatography. J Chromatogr B. 1995; B667:328-32.
15. Korbet SM, Makita Z, Firanek CA, Vlassara H. Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1993; 22:588-91.
16. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 1994; 46:216-22.
17. Makita Z, Bucala R, Rayfield RJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet. 1994; 343:1519-22.
18. Degenhardt TP, Grass L, Reddy S, Thorpe SR, Diamandis EP, Baynes JW. The serum concentration of the advanced glycation end-product Nε-(carboxymethyl)lysine is increased in uremia. Kidney Int. 1997; 52:1064-7.
19. Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze age-related increase of a pentose mediated collagen crosslink. J Clin Invest. 1990; 85:380-4.
20. Hricik DE, Schulak JA, Sell DR, Fogarty JF, Monnier VM. Pentose-derived glycation of plasma proteins after kidney or kidney-pancreas transplantation in patients with diabetic nephropathy. Kidney Int. 1992; 43:398-403.
21. Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE. Influence of dialysis modality on plasma and tissue concentrations of pentosidine. Am J Kidney Dis. 1995; 25:445-51.
22. Miyata T, Uedoa Y, Yoshida A, Sugiyama S, Iida Y, Jadoul M, et al. Clearance of pentosidine, an advanced glycation end product by different modalities of renal replacement therapy. Kidney Int. 1997; 51:880-7.
23. Nakayama M, Numata M, Hasegawa T, Kawaguchi Y, Sugiura M, Shibata K, et al. Suppression of advanced glycosylation end-products (AGE) formation by intermittent exposure to glucose-free solution [Abstract]. Perit Dial Int. 1997; 17:(Suppl 1):S98.
24. Mahiout A, Ehlerding G, Brunkhorst R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant. 1996; 11(Suppl 5):2-6.
25. Friedlander MA, Witko-Sarsat V, Nguyen AT, Ching WU Y, Labrune M, Verger C, et al. The advanced glycation endproduct pentosidine and monocyte activation in uremia. Clin Nephrol. 1996; 45:379-82.
26. Monnier VM, Nagaraj RH, Portero-Otin M, Glomb M, Elgawish A-H, Sell DR, et al. Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant. 1996; 11(Suppl 5):20-6.